Health Condition 1: L814- Other melanin hyperpigmentation
Conditions
Interventions
None listed
Sponsors
Sri Ganganagar College of Ayurvedic Science and Hospital
Sri Ganganagar College of Ayurvedic Science and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients having any allergy history of photosensitivity disorders. (2) Patients with similar Kshudra kushtha such as Nyachchha, Nilika. (3) Pregnant or lactating women (due to hormonal influence). (4) Patients with unstable melasma (rapid progression). (5) Patients with Kushta (major skin disorders) such as eczema, psoriasis, or fungal infections. (6) Female patients who are in the pre-menopausal or post-menopausal phases due to associated hormonal variations that may influence pigmentation will be excluded from the study. (7) Patients with Pitta-prakopa lakshanas like Daah, Agni and Atapa, Asahishnuta. Patients having any allergy history of photosensitivity disorders (8) Patients who have not used any topical depigmentation agents, hydroquinone, steroids, retinoid or procedures (peels/laser) in the last 4 weeks. (9) Patients having any systematic or serious illness like cardiovascular disease, malignancy, diabetic neuropathy, nephropathy retinopathy, diabetic foot etc. complicated cases will be excluded from study.
Exclusion criteria
Exclusion criteria: (1) Patients having any allergy history of photosensitivity disorders. (2) Patients with similar Kshudra kushtha such as Nyachchha, Nilika. (3) Pregnant or lactating women (due to hormonal influence). (4) Patients with unstable melasma (rapid progression). (5) Patients with Kushta (major skin disorders) such as eczema, psoriasis, or fungal infections. (6) Female patients who are in the pre-menopausal or post-menopausal phases due to associated hormonal variations that may influence pigmentation will be excluded from the study. (7) Patients with Pitta-prakopa lakshanas like Daah, Agni and Atapa, Asahishnuta. Patients having any allergy history of photosensitivity disorders (8) Patients who have not used any topical depigmentation agents, hydroquinone, steroids, retinoid or procedures (peels/laser) in the last 4 weeks. (9) Patients having any systematic or serious illness like cardiovascular disease, malignancy, diabetic neuropathy, nephropathy retinopathy, diabetic foot etc. complicated cases will be excluded from study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the therapeutic effect of Baladi Lepam and Raktachandanadi Lepam in reducing Vyanga (Melasma), assessed through objective clinical examination before and after treatment.Timepoint: 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| The study is expected to demonstrate improvement in the clinical signs and symptoms of Vyanga such as Shyava Varna (brownish-black discoloration), Tanu (thin superficial patches), Niruja (painless nature), and Mandala (patch characteristics) following the application of Baladi Lepam and Raktachandanadi Lepam. It is also expected to compare the relative efficacy of both Lepas based on changes in these parameters. Additionally, the study is expected to assess the safety, tolerability, and possible recurrence of pigmentation during the follow-up period.Timepoint: 6 month | — |
Countries
India
Contacts
Public ContactDr Sudesh Kumar Bhambhu
Sri Ganganagar College of Ayurvedic Science and Hospital
Outcome results
None listed